Market Overview:
The global altapharma market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for altapharmaceuticals. The prescription-based altapharma segment is expected to account for the largest share of the global altapharma market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The high growth in this segment can be attributed to factors such as increasing incidence of chronic diseases and technological advancements in prescription-based altapharmaceuticals. On the basis of application, clinics are expected to account for the largest share of the global altapharma market in 2018.
Product Definition:
Altapharma is a trade name for a range of complementary medicines. It is used to describe supplements that are not licensed as conventional medicines, but which may be helpful in the treatment of some conditions. Altapharma products can be bought over the counter without a prescription.
Prescription-based Altapharma:
Prescription-based Altapharma is a new formulation of ALTAPRASE. It’s an immunosuppressive drug that reduces the ability of the immune system to fight off infections. The drug was approved by FDA in 2015 for treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and in 2016 for other uses as well, including treatment of acute pain due to osteoarthritis and pain caused by shingles.
Daily-used Boiling Altapharma:
Boiling is a process in which the drug or medication is heated at a very high temperature to kill any microorganisms. This procedure does not affect the therapeutic value of drugs. The boiling process helps in maintaining the purity and potency of medications by eliminating any kind of contamination that may have entered into it during storage, transportation, or manufacturing procedures.
The daily-used Boiling Altapharma (BA) has been designed for oral use.
Application Insights:
The individual application segment held the largest share of over 70.0% in 2017. The daily-use boiling Altapharma is used for the treatment of individuals suffering from colds, cough, bronchitis and sinusitis. It is also used for individuals who are undergoing chemotherapy or radiation therapy as it helps to strengthen immunity against infections by strengthening white blood cells and natural killer cells in the body. Increasing awareness about alternative medicine among patients seeking medical treatment outside conventional healthcare settings will drive this segment over the forecast period.
The clinics application segment was valued at USD 1,000 million in 2017 owing to high usage of daily-use boiling Altapharma during flu pandemic year 2018 across clinics globally due to its ability to treat a wide range of infections with single dose preparation that reduces medication burden on patients along with providing faster healing process at a lower cost than conventional medicines do.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period on account of high adoption of generic drugs and rising healthcare expenditure. In addition, growing number of FDA approvals for new products and increasing R&D activities are also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to factors such as improving healthcare infrastructure, economic development, and rising disposable income among individuals & households. Moreover, government initiatives for creating awareness regarding various treatments available through modern medicines are expected to boost demand during the forecast period from 2018 to 2030 in this region alone). For instance; ‘Make in India’ initiative by Government of India has made it mandatory for all manufacturing companies operating within country not only comply with labor laws but also ensure that they do not employ child laborers or engage them in hazardous work environments (i.e.
Growth Factors:
- Increasing demand for Altapharma products due to their efficacy and safety.
- Growing awareness about the benefits of Altapharma products among consumers.
- Rising number of research studies validating the benefits of Altapharma products.
- increasing investment by companies in marketing and promotion of Altapharma products .
Scope Of The Report
Report Attributes
Report Details
Report Title
Altapharma Market Research Report
By Type
Prescription-based Altapharma, Daily-used Boiling Altapharma
By Application
Individual, Clinics, Other
By Companies
Swisse, American Health, Bayer AG, BioVit GMP Laboratories, Bliss GVS, By-health, dm-drogerie, JW Nutritional, Losan Pharma, Nutrilo, Strapharm, Tower Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Altapharma Market Report Segments:
The global Altapharma market is segmented on the basis of:
Types
Prescription-based Altapharma, Daily-used Boiling Altapharma
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Individual, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Swisse
- American Health
- Bayer AG
- BioVit GMP Laboratories
- Bliss GVS
- By-health
- dm-drogerie
- JW Nutritional
- Losan Pharma
- Nutrilo
- Strapharm
- Tower Laboratories
Highlights of The Altapharma Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription-based Altapharma
- Daily-used Boiling Altapharma
- By Application:
- Individual
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Altapharma Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Altapharma is a global pharmaceutical company that develops, manufactures and markets generic and branded medicines. The company has operations in more than 60 countries. Altapharma's products are sold through pharmacies, hospitals and other health care providers around the world.
Some of the major companies in the altapharma market are Swisse, American Health, Bayer AG, BioVit GMP Laboratories, Bliss GVS, By-health, dm-drogerie, JW Nutritional, Losan Pharma, Nutrilo, Strapharm, Tower Laboratories.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Altapharma Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Altapharma Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Altapharma Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Altapharma Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Altapharma Market Size & Forecast, 2018-2028
4.5.1 Altapharma Market Size and Y-o-Y Growth
4.5.2 Altapharma Market Absolute $ Opportunity
Chapter 5 Global Altapharma Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Altapharma Market Size Forecast by Type
5.2.1 Prescription-based Altapharma
5.2.2 Daily-used Boiling Altapharma
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Altapharma Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Altapharma Market Size Forecast by Applications
6.2.1 Individual
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Altapharma Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Altapharma Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Altapharma Analysis and Forecast
9.1 Introduction
9.2 North America Altapharma Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Altapharma Market Size Forecast by Type
9.6.1 Prescription-based Altapharma
9.6.2 Daily-used Boiling Altapharma
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Altapharma Market Size Forecast by Applications
9.10.1 Individual
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Altapharma Analysis and Forecast
10.1 Introduction
10.2 Europe Altapharma Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Altapharma Market Size Forecast by Type
10.6.1 Prescription-based Altapharma
10.6.2 Daily-used Boiling Altapharma
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Altapharma Market Size Forecast by Applications
10.10.1 Individual
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Altapharma Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Altapharma Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Altapharma Market Size Forecast by Type
11.6.1 Prescription-based Altapharma
11.6.2 Daily-used Boiling Altapharma
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Altapharma Market Size Forecast by Applications
11.10.1 Individual
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Altapharma Analysis and Forecast
12.1 Introduction
12.2 Latin America Altapharma Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Altapharma Market Size Forecast by Type
12.6.1 Prescription-based Altapharma
12.6.2 Daily-used Boiling Altapharma
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Altapharma Market Size Forecast by Applications
12.10.1 Individual
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Altapharma Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Altapharma Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Altapharma Market Size Forecast by Type
13.6.1 Prescription-based Altapharma
13.6.2 Daily-used Boiling Altapharma
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Altapharma Market Size Forecast by Applications
13.10.1 Individual
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Altapharma Market: Competitive Dashboard
14.2 Global Altapharma Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Swisse
14.3.2 American Health
14.3.3 Bayer AG
14.3.4 BioVit GMP Laboratories
14.3.5 Bliss GVS
14.3.6 By-health
14.3.7 dm-drogerie
14.3.8 JW Nutritional
14.3.9 Losan Pharma
14.3.10 Nutrilo
14.3.11 Strapharm
14.3.12 Tower Laboratories
